What Are the Side Effects of Buprenorphine?

Buprenorphine is one of the most widely used medications in modern opioid addiction treatment and is considered both safe and effective when prescribed under specialist medical supervision. At The OAD Clinic, buprenorphine forms part of bespoke outpatient treatment plans designed to help patients stabilise safely while reducing cravings and withdrawal symptoms.

As with any medication, however, patients may experience side effects during treatment - particularly during the early stages of induction or dose adjustment. Understanding the side effects of buprenorphine, how long they may last, and when to get medical advice can help patients feel more reassured and informed throughout recovery.

It is important to remember that most side effects are temporary and manageable, especially when treatment is carefully monitored by experienced clinicians.

Common Side Effects of Buprenorphine

Most patients tolerate buprenorphine well, but some side effects can occur as the body adjusts to the medication. In most cases, symptoms improve significantly within the first one to two weeks of treatment.

Despite common side effects, research published in the International Journal of Emergency Medicine has highlighted buprenorphine’s favourable safety profile compared with full opioid agonists when initiated appropriately under medical supervision (Hughes, T., Nasser, N. & Mitra, A., 2024).¹ It's safety and efficacy make tratment with buprenorphine one of the most popular options among rehab clinics.

Nausea

Nausea is one of the most commonly reported side effects of buprenorphine, particularly during the first few days of treatment. This occurs because opioid medications can affect the gastrointestinal system and slow digestion slightly. Symptoms are usually mild and often improve naturally once a stable dose is reached.

Headaches

Some patients experience headaches during induction or following dose changes. Dehydration, mild opioid receptor adjustment, or tension associated with withdrawal recovery can contribute to this symptom. Maintaining hydration and following medical guidance may help reduce discomfort.

Constipation

Like other opioid medications, buprenorphine can slow bowel motility, leading to constipation. However this is generally manageable through:

• hydration,

• dietary fibre,

• physical activity,

• and, where appropriate, clinician-approved medication support.

Drowsiness or Fatigue

Some patients report tiredness or mild sedation when first starting treatment.

These effects are usually temporary and often improve as the body adapts to the medication.

At The OAD Clinic, careful dose titration helps minimise excessive sedation while maintaining comfort and stability.

How Long Do Buprenorphine Side Effects Last?

One of the most common questions patients ask is: how long do buprenorphine side effects last? For most patients, mild side effects improve within approximately 3 to 14 days after beginning treatment or stabilising on an appropriate dose. The exact duration depends on several factors, including:

• dose strength

• individual metabolism

• previous opioid use

• liver function

• concurrent medications

• and whether long-acting formulations are used.

Research continues to support the importance of stable, medically supervised dosing. A 2024 analysis published in Drug and Alcohol Dependence found that longer retention in buprenorphine treatment was associated with reduced adverse outcomes following opioid overdose (Sugarman et al., 2024)².

During the early adjustment phase, patients may notice:

• nausea,

• headaches,

• fatigue,

• mild dizziness,

• or sleep disturbances.

These symptoms generally improve as opioid receptors adapt and blood concentrations stabilise, but how long these symptoms last depends on other factors mentioned above.

At The OAD Clinic, clinicians use carefully structured induction protocols and bespoke dosing plans to reduce unnecessary side effects and improve toleration to treatment.

Long-acting injectable options such as the Buvidal injection treatment may also help some patients achieve more stable symptom control by avoiding daily fluctuations associated with sublingual dosing.

Patients should always speak with their clinician if side effects:

• worsen,

• persist beyond several weeks,

• or interfere significantly with day-to-day functioning.

  
  

What Are the Bad Side Effects of Buprenorphine?

Patients often ask: what are the bad side effects of buprenorphine? The fact is that serious complications are uncommon when treatment is properly supervised, but certain risks can occur, particularly when buprenorphine is combined with alcohol, benzodiazepines, or other sedative medications. Potential serious side effects include:

• respiratory depression

• severe drowsiness

• allergic reactions

• liver dysfunction

• confusion

• or loss of consciousness.

Patients should seek urgent medical attention if they experience:

• difficulty breathing

• severe swelling

• chest pain

• fainting

• or yellowing of the skin or eyes.

Despite these risks, buprenorphine remains substantially safer than many full opioid agonists because of its partial agonist properties and “ceiling effect.” A 2026 study published in Addictive Behaviors reported that overdose risk was significantly lower during periods when patients remained actively prescribed buprenorphine compared with periods without treatment (Chambers et al., 2026)³.

The US National Institutes of Health has also highlighted evidence suggesting that appropriately dosed buprenorphine treatment may improve outcomes and reduce emergency care utilisation in opioid use disorder (NIH, 2024)⁴.

At The OAD Clinic, patients undergo comprehensive medical assessment before treatment begins to reduce risk and ensure appropriate monitoring throughout recovery.

Managing Side Effects Privately at The OAD Clinic

One of the key advantages of specialist private addiction treatment is the ability to tailor medication plans closely to the patient’s needs. At The OAD Clinic, treatment plans are designed on an outpatient basis and individually using:

• careful dose titration,

• ongoing clinical reviews (in-person and online)

• medication adjustments

• and long-acting treatment options where appropriate.

For some patients, transitioning to long-acting injectable formulations such as Buvidal may improve toleration by:

• reducing daily dosing fluctuations

• improving consistency

• lowering psychological preoccupation with medication

• and supporting greater lifestyle stability.

Patients also benefit from:

• discreet outpatient treatment

• continuity of care

• rapid access to clinicians

• and ongoing monitoring throughout treatment

Importantly, patients are encouraged to communicate openly about side effects rather than discontinuing medication independently. Suddenly stopping buprenorphine without supervision may increase the risk of withdrawal symptoms and relapse.

Dr Oscar D’Agnone and the clinical team focus heavily on reducing unnecessary side effects while maintaining effective opioid stabilisation.

Long term Safety and Monitoring

Buprenorphine has been extensively studied and is considered safe for long-term use when prescribed appropriately.

At The OAD Clinic, patients receiving long-term buprenorphine treatment attend regular medical reviews to monitor:

• symptom control

• medication effectiveness

• liver function where appropriate

• mental wellbeing

• and overall recovery progress

Treatment plans can be adjusted over time depending on:

• patient goals

• stability

• side effects

• and broader health considerations

For many individuals, long-term medically supervised treatment provides greater stability, safety, and protection against relapse.

Final Words

The side effects of buprenorphine are usually mild, temporary, and manageable under specialist medical supervision. While some patients experience symptoms such as nausea, headaches, constipation, or fatigue during the adjustment phase, these effects often improve significantly once treatment is stabilised.

At The OAD Clinic, patients benefit from bespoke outpatient treatment plans designed to maximise comfort, safety, and long-term recovery outcomes.

To learn more about treatment options, including the buvidal injection, contact The OAD Clinic for a confidential consultation.

Frequently Asked Questions (FAQ)

How long do buprenorphine side effects last for new patients? 

Most common side effects of buprenorphine typically last between 3 to 14 days as your system adjusts. If you find that symptoms like headaches or nausea persist beyond two weeks, our specialists at The OAD Clinic can review your dosage or switch you to a long-acting injection to improve stability.

What are the bad side effects of buprenorphine I should know?

Serious or "bad" side effects include severe drowsiness, difficulty breathing, or yellowing of the eyes and skin, which can indicate liver distress. While these are rare, they require immediate medical attention. The OAD Clinic conducts thorough health screenings before treatment to ensure you are at a low risk for these complications.

Do the side effects of buprenorphine go away on their own?

Yes, the vast majority of side effects are temporary and will resolve without specific treatment as you reach a stable dose. Maintaining hydration and following the nutritional advice provided by The OAD Clinic can also help your body process the medication more comfortably during the initial induction phase of your recovery.

Can I drive while experiencing side effects?

You should not drive or operate heavy machinery until you know how the side effects of buprenorphine affect you, particularly if you feel dizzy or sleepy. Once your dose is stabilised by your consultant at The OAD Clinic, most patients find they can resume normal activities safely without impairment or significant side effects.

Why does buprenorphine cause constipation?

Like all opioids, buprenorphine slows down the digestive system, which can lead to constipation. This is a common side effect that we manage at The OAD Clinic through bespoke lifestyle guidance and, if necessary, safe medicinal support to ensure your physical comfort is maintained throughout your treatment programme.

1. Hughes, T., Nasser, N. & Mitra, A.  (2024) 'Overview of best practices for buprenorphine initiation in the emergency department.‘, International Journal of Emergency Medicine, 17(23). Available at: Springer – International Journal of Emergency Medicine (Accessed: 18 May 2026).

2. Sugarman, O. K. , Saloner, B., Richards, T. M., Lasser, E. C., Heath, T., Idries, S., Weiner, J. P. and Bandara, S. (2024) ‘Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases’, Drug and Alcohol Dependence, 258, p. 111262. Available at: ScienceDirect – Drug and Alcohol Dependence (Accessed: 18 May 2026).

3. C. Chambers et al. (2026) 'Risk of opioid overdose during buprenorphine treatment for opioid use disorder in the fentanyl era', Journal of Addictive Behaviors, vol. 175:108603. Available at: Addictive Behaviors  (Accessed: 11 May 2026).

4. National Institutes of Health (2024) 'Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder'. Available at: NIH News Release (Accessed: 11 May 2026).